Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2-Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

导出原文传递

翻译打印收藏纠错

作者： Al-Batran, Salah-Eddin ^[1] ; Moorahrend, Enno ^[2] ; Maintz, Christoph ^[3] ; Goetze, Thorsten O. ^[4] ; Hempel, Dirk ^[5] ; Thuss-Patience, Peter ^[6] ; Gaillard, Vincent E. ^[7] ; Hegewisch-Becker, Susanna

作者单位： Zentrum Hamatol & Onkol MVZ GmbH, Porta Westfalica, Germany ^[1] Hamatol Onkol Praxis Wurselen, Wurselen, Germany ^[2] Charite Univ Med Berlin, Med Klin Mit Schwerpunkt Hamatol Onkol & Tumorimm, Campus Virchow Klinikum ^[3] Hamatol Onkol Praxis Eppendorf, Hamburg, Germany ^[4] Inst Clin Canc Res IKF, Krankenhaus Nordwest, Steinbacher Hohl 2-26, D-60488 Frankfurt, Germany ^[5] Onkol Zentrum Donauworth, Donauworth, Germany ^[6] Roche Pharma AG, Med Affairs, Grenzach Wyhlen, Germany ^[7]

关键词 Metastatic adenocarcinoma of the stomach or gastroesophageal junction Trastuzumab Human epidermal growth receptor 2 Backbone chemotherapy Noninterventional study Real-world data

发布时间 2020-12-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交